University of Washington: Clinical Trials

1,987 trials sponsored by University of Washington, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1256 completed, 230 recruiting, 155 unknown, 132 terminated. 1041 Not applicable, 351 Phase 2, 160 Phase 1, 127 Phase 4, 114 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1041Completed 662, Recruiting 139, Unknown 88, Active not recruiting 48, Not yet recruiting 34, Terminated 34, Withdrawn 18, Enrolling by invitation 17, Suspended 1
Phase 2351Completed 207, Terminated 56, Recruiting 39, Active not recruiting 23, Unknown 11, Withdrawn 11, Not yet recruiting 3, Suspended 1
Phase 1160Completed 112, Terminated 19, Recruiting 11, Active not recruiting 7, Unknown 6, Withdrawn 4, Suspended 1
Phase 4127Completed 84, Recruiting 12, Terminated 11, Unknown 8, Not yet recruiting 4, Active not recruiting 3, Enrolling by invitation 2, Withdrawn 2, Suspended 1
Phase 3114Completed 80, Terminated 12, Recruiting 8, Unknown 7, Active not recruiting 6, Enrolling by invitation 1
Early Phase 113Completed 8, Active not recruiting 2, Enrolling by invitation 1, Recruiting 1, Unknown 1

Follow University of Washington: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hybrid Type 1 Trial of a Parent-Based Intervention Addressing Social Media and Adolescent Alcohol Use
Combined Alcohol and Social Media PBI and PFI, Alcohol and Social Media PBI, Power of Parents - Adolescent Alcohol Use
Not applicableNot yet recruitingThe University of Texas at Arlington9002027-07-012026-10-27
Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya
Systems Analysis and Improvement Approach (SAIA) - HIV
Not applicableNot yet recruitingRhode Island Hospital1842027-02-012026-08-12
A Hybrid Effectiveness-Implementation Trial of Urine Point-of-Care Assay to Increase PrEP Adherence Among Women in Kenya
POC urine TFV test with DLFB - PrEP Adherence Monitoring
Not applicableNot yet recruitingUniversity of Washington4002027-02-012026-07-24
VOCALE: A Digital Intervention to Improve Quality of Life and Reduce Frailty Among Older Adults in Retirement Communities
VOCALE Healthy Aging Online Program - Frailty, Quality of Life
Not applicableNot yet recruitingUniversity of Washington1282027-01-152026-10-06
Dynamic, Real-world Learning, Innovative Mobility, and Versatile Exploration (DRIVE): Evaluating a Dose-matched Developmental Powered Mobility Intervention for Young Children With Cerebral Palsy
Permobil Explorer Mini, MORE-PT - Cerebral Palsy
Not applicableNot yet recruitingUniversity of Washington482027-01-012026-10-15
Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIV
Neurodevelopmental screening - Neurodevelpmental Delays, Neurodevelopment
Not applicableNot yet recruitingUniversity of Washington50002027-01-012026-03-09
Lead Exposure Intervention Program
Home visit with tailored messages, In-clinic lead risk reduction intervention - Lead Exposure, High Blood Lead Level
Not applicableNot yet recruitingUniversity of Washington5002027-01-012026-09-30
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia
VOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia, Standard of Care Educational Materials - Lewy Bodies Disease, Depression Disorder
Not applicableNot yet recruitingUniversity of Washington2202026-12-012026-06-09
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
Nadofaragene Firadenovec, Durvalumab, Gemcitabine - Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2Not yet recruitingUniversity of Washington332026-12-012026-10-26
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Lutetium Lu 177 Vipivotide Tetraxetan, Cell-free Circulating Tumor DNA Assay, Computed Tomography - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2RecruitingUniversity of Washington642026-11-152026-10-19
Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa
Friendship Bench, Infant and Young Child Feeding (IYCF) Curriculum, Play-Based Curriculum - Neurodevelopment, Child Growth
Not applicableNot yet recruitingUniversity of Washington12602026-11-012026-03-03
Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable Finances
Virtual Community of Practice, Enhanced Standard of Care - HIV Prevention
Not applicableNot yet recruitingUniversity of Washington5002026-11-012026-09-18
A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Biospecimen Collection - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2Not yet recruitingUniversity of Washington602026-11-012026-10-16
Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease
CHW Delivered SAP Adherence Supports - Rheumatic Heart Disease in Children
Not yet recruitingChildren's Hospital Medical Center, Cincinnati3082026-11-012026-10-13
Study Comparing Osteoarthritis Programs
I'm Walking, Walk With Ease - Osteoarthritis
Not applicableNot yet recruitingWeill Medical College of Cornell University2002026-11-012026-10-27
Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black Women
Chatbot - Breast Cancer
Not applicableNot yet recruitingUniversity of Washington8732026-10-262026-10-05
Inherited and Environmental Risks Acting on Body Weight
Diet modification - Genetics, Obesity
Not applicableEnrolling by invitationUniversity of Washington1102026-10-152026-10-02
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
Samuraciclib, Computed Tomography, Endoscopic Ultrasound Biopsy - Resectable Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma
Phase 1RecruitingUniversity of Washington152026-10-152026-09-21
A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant
Aerobic Exercise, Resistance Training, Biospecimen Collection - Acute Myeloid Leukemia
Not applicableRecruitingUniversity of Washington302026-10-152026-09-11
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-152026-10-19

Showing 20 of 1987. Sign in to see all of them.

Conditions studied

Depression (101)  ·  Breast Neoplasms (66)  ·  HIV Infections (63)  ·  Acquired Immunodeficiency Syndrome (58)  ·  Chronic Pain (51)  ·  Stress Disorders, Post-Traumatic (51)  ·  Prostatic Neoplasms (47)  ·  Cardiovascular Diseases (46)  ·  Pain (42)  ·  Anxiety Disorders (40)  ·  Substance-Related Disorders (38)  ·  Motor Activity (36)  ·  Alzheimer Disease (33)  ·  Obesity (32)  ·  Brain Injuries, Traumatic (31)

Interventions

Magnetic Resonance Spectroscopy (48)  ·  Cognitive Behavioral Therapy (25)  ·  Therapeutics (25)  ·  Specimen Handling (24)  ·  Cyclophosphamide (20)  ·  Doxorubicin (20)  ·  Standard of Care (20)  ·  Biopsy (19)  ·  Motivational Interviewing (19)  ·  Rituximab (19)  ·  Ethanol (18)  ·  pembrolizumab (18)  ·  Etoposide (17)  ·  Methods (17)  ·  Carboplatin (16)

Countries

United States (1603)  ·  Kenya (112)  ·  Canada (47)  ·  South Africa (33)  ·  Uganda (29)  ·  Malawi (14)  ·  Peru (11)  ·  Bangladesh (9)  ·  Mali (9)  ·  Mozambique (8)  ·  Zambia (8)  ·  India (7)  ·  United Kingdom (7)  ·  Australia (6)  ·  Ethiopia (6)

Top investigators

Anna Wald, MD, MPH (11)  ·  Hannah Linden (11)  ·  Jonathan Himmelfarb, MD (10)  ·  Connie Celum, MD, MPH (9)  ·  David R Flum, MD, MPH (8)  ·  Jing Zeng (8)  ·  Michael Schweizer (8)  ·  Rachel L Winer, PhD, MPH (8)  ·  Aaron Lyon, PhD (7)  ·  James A Taylor, MD (7)  ·  Jared Baeten, MD, PhD (7)  ·  Kassoum Kayentao, MD, MPH, PhD (7)  ·  Lupe Salazar (7)  ·  Pamela Becker (7)  ·  Robert Montgomery (7)

Results publications

PMID 22225814, PMID 31599736, PMID 32779730, PMID 33884617, PMID 35012490, PMID 35842614, PMID 37795783, PMID 40200326, PMID 17494097, PMID 20378927, PMID 22772084, PMID 23533230, PMID 25072443, PMID 25084698, PMID 25216871, PMID 25245415, PMID 26708287, PMID 27308805, PMID 28252569, PMID 29108000, PMID 29301785, PMID 30297124, PMID 31499231, PMID 32368793, PMID 32620184, PMID 32813276, PMID 32940089, PMID 33017106, PMID 33115916, PMID 33184642, PMID 33247553, PMID 33908182, PMID 33910159, PMID 34134520, PMID 35398399, PMID 35710444, PMID 35723668, PMID 35822945, PMID 37085877, PMID 37146219, PMID 38719439, PMID 39360568, PMID 39630076, PMID 40243391, PMID 41085955, PMID 41680079, PMID 41944009, PMID 10582782, PMID 10628520, PMID 11071210

NIH funding

P30CA015704 (85), P50MH115837 (13), P50CA097186 (8), U01HL077863 (8), U54HD042454 (6), K23HD045386 (4), KL2TR002317 (4), P01DK043881 (4), P50MH129708 (4), U19MH108206 (4), U24CA275417 (4), U54DE014254 (4), UG1CA275402 (4), UL1TR002319 (4), P01AI030731 (3)